The recognition highlights the company’s leadership in artificial intelligence-assisted video production to develop a series of educational content videos to support a client’s need.
Tag Archive for: artificial intelligence
The deal couples Novo Nordisk’s experience in diabetes with Dewpoint’s discovery and artificial intelligence platform. The companies will work to discover potential molecule drugs against multiple condensate targets.
Unlearn.AI, which has built a machine learning platform that creates “digital twin” profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate regulatory approval.
A Q&A with Alister Campbell, VP, global head of science and technology at Dotmatics.
Utilizing social listening data to understand patterns and trends in patient behaviors can now make that journey easier, improve quality of life and result in better outcomes for patients.
Med Ad News talked to Ittai Dayan, M.D., co-founder and CEO of Rhino Health, about federated learning in clinical trials.
Regulatory affairs teams within lifescience organizations possess a unique opportunity to drive connected intelligence across the enterprise to support critical operations relating to drug development, safety, and regulatory verticals.
AI technologies have the capacity to revolutionize the practice of medicine – if human HCPs can learn to trust them first.
The combined capabilities will help improve trial lifecycles for patients, sites, and sponsors.